HER2 Support Group Forums - View Single Post - Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours

News · 01-08-2012, 10:20 PM

Circadian Technologies Limited announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.

More...

01-08-2012, 10:20 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,725	Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours Circadian Technologies Limited announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre. More...